CSPC PHARMACEUTICAL GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.450 HKD | +0.91% |
|
+1.83% | -6.90% |
| 01:33am | CSPC Pharmaceutical Gets China Nod for Registration of Tumor Drug | MT |
| 01-20 | CSPC Pharmaceutical Group Limited Announces Regorafenib Tablets Obtains Drug Registration Approval | CI |
Chart calendar CSPC Pharmaceutical Group Ltd.
f2c6f971fe856540.b9zsOiO-XTpRgd1nXduTo0xw1N1BJxqQwFFvr4G71h0.Pai2WA6KMFg35YU0N6r27hs9spEOflvAlGEo_cPzvE48m6lYQYY2aXzRhA~e969f9ad866d9ff0f2f9e8bc1b169ac1
Upcoming events on CSPC Pharmaceutical Group Ltd.
Past events on CSPC Pharmaceutical Group Ltd.
| 2024-11-14 23:01 | Q3 2024 Earnings Release |
| 2024-10-30 | Détachement de for dividende intermédiaire |
| 2024-08-20 | Q2 2024 Earnings Release |
| 2024-05-30 | Final dividend |
| 2024-05-27 22:00 | Annual General Meeting |
| 2024-05-26 | Q1 2024 Earnings Release |
| 2024-03-19 | Q4 2023 Earnings Release |
| 2023-11-29 | Q3 2023 Earnings Release |
| 2023-09-06 | Détachement de for dividende intermédiaire |
| 2023-08-22 | Q2 2023 Earnings Release |
| 2023-06-04 | Final dividend |
| 2023-05-30 22:00 | Annual General Meeting |
| 2023-05-24 | Q1 2023 Earnings Release |
| 2023-05-08 | Macquarie DELTAH China Conference |
| 2023-03-21 | Q4 2022 Earnings Release |
| 2022-11-22 | Q3 2022 Earnings Release |
| 2022-09-07 | Détachement de for dividende intermédiaire |
| 2022-08-23 | Interim 2022 Earnings Release |
| 2022-05-30 | Détachement de for final dividend |
| 2022-05-24 | Q1 2022 Earnings Release |
Past dividends on CSPC Pharmaceutical Group Ltd.
| 2024-10-30 | Interim Payment 0.16 HKD |
| 2024-05-30 | Final Payment 0.14 HKD |
| 2023-09-06 | Interim Payment 0.14 HKD |
| 2023-06-04 | Final Payment 0.11 HKD |
| 2022-09-07 | Interim Payment 0.1 HKD |
| 2022-05-30 | Final Payment 0.1 HKD |
| 2021-09-09 | Interim Payment 0.08 HKD |
| 2021-05-23 | Final Payment 0.09 HKD |
| 2020-09-09 | Interim Payment 0.06 HKD |
| 2020-06-17 | Annual 0.2 HKD |
| 2019-05-29 | Annual 0.18 HKD |
| 2018-05-29 | Annual 0.15 HKD |
| 2017-05-30 | Annual 0.12 HKD |
| 2016-06-01 | Annual 0.11 HKD |
| 2015-05-27 | Annual 0.1 HKD |
| 2014-05-22 | Annual 0.08 HKD |
| 2013-05-26 | Annual 0.1 HKD |
| 2011-05-18 | Annual 0.24 HKD |
| 2010-05-18 | Annual 0.24 HKD |
| 2009-05-20 | Annual 0.2 HKD |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million HKD | Released Forecast Spread | 34 309 34 163 0.43% | 35 292 34 957 0.96% | 34 175 34 801 -1.8% | 32 975 | 34 256 | 36 242 |
|
EBITDA Million HKD | Released Forecast Spread | 9 431 8 966 5.2% | 9 148 9 208 -0.66% | 8 615 9 271 -7.08% | 8 375 | 8 741 | 9 487 |
|
EBIT Million HKD | Released Forecast Spread | 8 366 8 159 2.54% | 7 952 8 116 -2.02% | 7 400 8 079 -8.4% | 7 164 | 7 284 | 7 803 |
|
Earnings before Tax (EBT) Million HKD | Released Forecast Spread | 8 430 8 370 0.72% | 8 650 8 341 3.71% | 8 030 8 336 -3.68% | 6 925 | 7 439 | 7 999 |
|
Net income Million HKD | Released Forecast Spread | 6 901 6 873 0.41% | 6 949 6 736 3.16% | 6 382 6 692 -4.63% | 5 561 | 5 951 | 6 381 |
|
EPS HKD | Released Forecast Spread | 0,58 0,60 -2.99% | 0,58 0,56 3.71% | 0,54 0,56 -4.57% | 0,50 | 0,51 | 0,55 |
| Announcement Date | 22/03/22 | 22/03/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | September | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million HKD | Released Forecast Spread | 17 479 18 340 -4.7% | 8 938 9 062 -1.37% | 8 626 8 846 -2.49% | 8 522 8 547 -0.29% | 8 242 8 544 -3.54% | 9 690 8 073 20.04% | 7 974 9 154 -12.89% | 6 887 8 015 -14.08% | 7 555 | 7 942 | 8 483 | 8 872 | |
|
EBIT Million HKD | Released Forecast Spread | 3 697 4 290 -13.81% | 2 000 2 135 -6.3% | 2 051 1 872 9.56% | 1 865 2 011 -7.28% | 1 517 1 998 -24.06% | 2 258 1 678 34.56% | 1 946 2 040 -4.59% | 1 060 1 443 -26.55% | 1 492 | 1 498 | 1 715 | 1 734 | |
|
Earnings before Tax (EBT) Million HKD | Released Forecast Spread | 4 379 4 336 1% | 1 977 2 201 -10.21% | 2 139 1 980 8.04% | 2 111 2 200 -4.04% | 1 934 2 169 -10.86% | 1 921 1 505 27.63% | 2 206 2 124 3.85% | 1 016 1 728 -41.21% | 1 389 | ||||
|
Net income Million HKD | Released Forecast Spread | 3 543 3 572 -0.8% | 1 586 1 787 -11.27% | 1 653 1 596 3.58% | 1 672 1 772 -5.62% | 1 498 1 761 -14.93% | 1 740 1 209 43.86% | 1 537 1 782 -13.76% | 815 1 372 -40.57% | 1 087 | ||||
|
EPS HKD | Released Forecast Spread | 0,30 0,28 5.29% | 0,13 0,15 -10.09% | 0,14 0,14 -1% | 0,14 0,14 -0.7% | 0,13 0,15 -12.97% | 0,15 0,13 14.7% | 0,13 0,15 -14.5% | 0,07 0,11 -37.93% | 0,13 | 0,11 | 0,12 | 0,12 | 0,14 |
| Announcement Date | 22/03/23 | 25/05/23 | 23/08/23 | 30/11/23 | 20/03/24 | 27/05/24 | 21/08/24 | 15/11/24 | - | - | - | - | - |
More events
Past sector events for CSPC Pharmaceutical Group Ltd.
| Today | AARTI PHARMALABS LIMITED: Q3 2025 Earnings Release (Projected) |
| 2025-01-10 07:00 | TILRAY BRANDS, INC.: Q2 2025 Earnings Release |
| 2025-01-10 04:09 | LOTUS PHARMACEUTICAL CO., LTD.: December 2024 Sales and Revenue Release |
| 2025-01-09 18:50 | BORA PHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
| 2025-01-09 05:25 | SCINOPHARM TAIWAN, LTD.: December 2024 Sales and Revenue Release |
| 2025-01-08 | HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2024 Earnings Release |
| 2025-01-08 03:17 | CALIWAY BIOPHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
| 2024-12-10 11:45 | MEDINCELL S.A.: Q2 2025 Earnings Release |
| 2024-12-10 04:02 | LOTUS PHARMACEUTICAL CO., LTD.: November 2024 Sales and Revenue Release |
| 2024-12-10 01:29 | CENTER LABORATORIES, INC.: November 2024 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1093 Stock
- Calendar CSPC Pharmaceutical Group Ltd.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition